Duopharma eyes packaging for Covid-19 vaccines


Duopharma Biotech Bhd managing director Leonard Ariff Abdul Shatar says the company is currently in discussions with the Science, Technology and Innovation Ministry and the Health Ministry on its capability to take on the potential fill-and-finish processes for Covid-19 vaccines.

AMIDST the global race by pharmaceutical companies to develop vaccines for the coronavirus (Covid-19) pandemic, a few local players were thrust into the limelight.

The share prices of local pharmaceutical companies Duopharma Biotech Bhd and Pharmaniga Bhd recently soared to hit their all-time highs.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Duopharma , Pharmaniga , Covid-19 ,

   

Next In Business News

Lotte Chemical Titan’s 1Q net loss narrows to RM178mil
Pasukhas gets data centre construction job worth RM56.98mil
FBM KLCI bucks regional downtrend
Indonesia's inflation rate eases slightly in April
Main Market-bound Feytech holdings aims to raise RM114.66mil from IPO
Asian equities slip on Fed decision; Indonesia drops as inflation rate eases
TA Investment declares distributions for two funds
Yinson Production completes US$1.3bil project financing for Agogo FPSO
ACE Market-bound Smart Asia chemical aims to raise RM37.4mil from IPO
Pandora raises full-year forecast on strong U.S. sales

Others Also Read